Alamance Regional Cancer Center — Burlington, North Carolina

Alamance Regional Cancer Center is a clinical research site located in Burlington, North Carolina, United States 27215.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Alamance Regional Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Sponsors: Celgene, Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Alamance Regional Cancer Center?

Alamance Regional Cancer Center has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Alamance Regional Cancer Center conducted?

Alamance Regional Cancer Center has 2 clinical trials on record. Their work covers Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer.

Is Alamance Regional Cancer Center accredited by Crixeo Health?

Alamance Regional Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Alamance Regional Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.